# Cohero Health

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/cohero-health

- Industry: Medical Devices & Equipment
- Headquarters: New York, US
- Website: www.coherohealth.com
- Total disclosed funding: $13M
- Latest round: Series A (Mar 15, 2017)
- Investors on record: 10

## About

Cohero Health, Inc is a healthcare technology company focused on enhancing the management of pulmonary diseases through innovative digital solutions and integrated systems that promote patient engagement and improved health outcomes.Founded in 2012 in New York, US, Cohero Health, Inc specializes in digital health solutions for pulmonary disease management. The company raised USD 1.5 mn in Series A funding in March 2017, with investors including Omron Healthcare, Inc. and Samsung NEXT Ventures. CEO Joseph Condurso leads the company, which has completed a total of 4 deals.Cohero Health, Inc provides comprehensive solutions for managing pulmonary diseases such as asthma and chronic obstructive pulmonary disease (COPD). Their BreatheSmart platform integrates AI-based tools and smart sensors, facilitating patient care from prevention to ongoing management. The platform features a user-friendly smartphone application that consolidates data from connected devices, enhancing adherence monitoring, lung function assessment, and symptom reporting for patients, healthcare providers, and health coaches.Cohero Health, Inc generates revenue through subscription models and partnerships with healthcare providers. Its BreatheSmart platform is integrated into care management systems of healthcare institutions, enabling remote monitoring and enhanced data analytics. Clients, including hospitals and clinics, typically pay subscription fees for access to the platform and associated services, which include training and support resources for healthcare professionals. The use of connected devices in patient care plans further enriches their revenue model by enabling ongoing data collection and treatment optimization.Cohero Health, Inc aims to enhance its product offerings and expand into new markets. Following its Series A funding of USD 1.5 mn in March 2017, the company is designing new features for the BreatheSmart platform. Plans for geographic expansion include targeting North American and European markets, with specific timelines for rollout yet to be disclosed. The recent funding will be instrumental in developing these initiatives and supporting further innovations.

## Funding rounds

- Series A, Mar 15, 2017, $1.5M — Samsung NEXT Ventures, Omron Healthcare, Inc.
- Series A, Nov 2, 2016, $9M — Heitkamp and Thumann Group, BioAdvance, Zaffre Investments, Three Leaf Ventures, P5 Health Ventures, GIS Strategic Ventures
- Seed, Dec 15, 2015, $2M — BioAdvance, Zaffre Investments, Three Leaf Ventures, Swanhill Capital, AngelList

## Investors

- BioAdvance (https://capitalatlas.ai/funds/bioadvance) — Seed, Series A
- Zaffre Investments (https://capitalatlas.ai/funds/zaffre-investments) — Seed, Series A
- Three Leaf Ventures (https://capitalatlas.ai/funds/three-leaf-ventures) — Seed, Series A
- Swanhill Capital (https://capitalatlas.ai/funds/swanhill-capital) — Seed
- AngelList — Seed
- Heitkamp and Thumann Group — Series A
- P5 Health Ventures (https://capitalatlas.ai/funds/p5-health-ventures) — Series A
- GIS Strategic Ventures (https://capitalatlas.ai/funds/gis-strategic-ventures) — Series A
- Samsung NEXT Ventures (https://capitalatlas.ai/funds/samsung-next-ventures) — Series A
- Omron Healthcare, Inc. — Series A